Martin SA, Haren MT, Marshall VR, Lange K, Wittert GA. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2011;29(2):179–84. https://doi.org/10.1007/s00345-010-0605-8.
Park S, Lee KS, Choi M, Lee M. Factors associated with quality of life in patients with benign prostatic hyperplasia, 2009-2016. Medicine (Baltimore). 2022;101(36):e30091. https://doi.org/10.1097/md.0000000000030091.
Article PubMed PubMed Central Google Scholar
Zhang W, Ding Z, Peng Y, Wang H, Sun Y, Ke H, et al. LUTS/BPH increases the risk of depressive symptoms among elderly adults: a 5-year longitudinal evidence from CHARLS. J Affect Disord. 2024;367:210–8. https://doi.org/10.1016/j.jad.2024.08.205.
Patelli G, Altieri VM, Ierardi AM, Carnevale A, Chizzoli E, Baronchelli F, et al. Transperineal laser ablation of the prostate for symptomatic benign prostatic hyperplasia: long-term follow-up in 40 patients. J Vasc Interv Radiol. 2024;35(8):1187–93. https://doi.org/10.1016/j.jvir.2024.04.023.
Navin PJ, Thompson SM, Kurup AN, Lee RA, Callstrom MR, Castro MR, et al. Radiofrequency ablation of benign and malignant thyroid nodules. Radiographics. 2022;42(6):1812–28. https://doi.org/10.1148/rg.220021.
Nguyen N, Rode A, Trillaud H, Aubé C, Manichon AF, Hocquelet A, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease. Liver Int. 2022;42(4):905–17. https://doi.org/10.1111/liv.15129.
Article CAS PubMed Google Scholar
Dello Russo A, Compagnucci P, Anselmino M, Schillaci V, Campanelli F, Ascione MR, et al. Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation: results of a multicenter, real-world experience. Heart Rhythm. 2024;21(9):1526–36. https://doi.org/10.1016/j.hrthm.2024.05.042.
Marien A, Gill I, Ukimura O, Betrouni N, Villers A. Target ablation--image-guided therapy in prostate cancer. Urol Oncol. 2014;32(6):912–23. https://doi.org/10.1016/j.urolonc.2013.10.014.
Clemmesen TBR, Achiam MP, Pedersen CR, Larsen PN. Radiofrequency ablation for liver tumour treatment. Ugeskr Laeger. 2019;181(36):V12180868–V12180868.
Jung SL, Baek JH, Lee JH, Shong YK, Sung JY, Kim KS, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018;19(1):167–74. https://doi.org/10.3348/kjr.2018.19.1.167.
Article PubMed PubMed Central Google Scholar
Cesareo R, Pacella CM, Pasqualini V, Campagna G, Iozzino M, Gallo A, et al. Laser ablation versus radiofrequency ablation for benign non-functioning thyroid nodules: six-month results of a randomized, parallel, open-label, trial (LARA trial). Thyroid. 2020;30(6):847–56. https://doi.org/10.1089/thy.2019.0660.
Nunes TF, Rocha RD, Ilgenfritz BRW, Stefanini FS, Fornazari VAV, Mariotti GC, et al. Ultrasound-guided transperineal prostate thermal ablation (TPTA) for benign prostatic hyperplasia: feasibility of an outpatient procedure using radiofrequency ablation. Cardiovasc Intervent Radiol. 2025. https://doi.org/10.1007/s00270-024-03958-9.
Filippiadis DK, Pereira PL, Hausegger KA, Binkert CA. CIRSE classification system for complications’ reporting: a project evaluation process. Cardiovasc Intervent Radiol. 2024;47(8):1160–2. https://doi.org/10.1007/s00270-024-03772-3.
Pacella CM, Patelli G, Iapicca G, Manenti G, Perretta T, Ryan CP, et al. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study. Prostate Cancer Prostatic Dis. 2019;23(2):356–63. https://doi.org/10.1038/s41391-019-0196-4.
Article CAS PubMed Google Scholar
Manenti G, Perretta T, Calcagni A, Ferrari D, Ryan CP, Fraioli F, et al. 3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia. Eur Radiol Exp. 2021. https://doi.org/10.1186/s41747-021-00239-9.
Article PubMed PubMed Central Google Scholar
Frego N, Saita A, Casale P, Diana P, Contieri R, Avolio PP, et al. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience. World J Urol. 2021;39(10):3867–73. https://doi.org/10.1007/s00345-021-03685-7.
Sessa F, Polverino P, Siena G, Bisegna C, Lo Re M, Spatafora P, et al. Transperineal laser ablation of the prostate (TPLA) for lower urinary tract symptoms due to benign prostatic obstruction. J Clin Med. 2023. https://doi.org/10.3390/jcm12030793.
Article PubMed PubMed Central Google Scholar
de Rienzo G, Lorusso A, Minafra P, Zingarelli M, Papapicco G, Lucarelli G, et al. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction. Eur Urol. 2021;80(1):95–103. https://doi.org/10.1016/j.eururo.2020.08.018.
Article CAS PubMed Google Scholar
Destefanis P, Sibona M, Vitiello F, Vercelli E, Micai L, Montefusco G, et al. Trans-perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-023-00736-5.
Bernardi S, Giudici F, Cesareo R, Antonelli G, Cavallaro M, Deandrea M, et al. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian Minimally Invasive Treatments of the Thyroid Group. Thyroid. 2020;30(12):1759–70. https://doi.org/10.1089/thy.2020.0202.
Article CAS PubMed Google Scholar
Lo Re M, Polverino P, Rivetti A, Pecoraro A, Saladino M, Pezzoli M, et al. Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study. World J Urol. 2024;42(1):402. https://doi.org/10.1007/s00345-024-05077-z.
Article PubMed PubMed Central Google Scholar
Minafra P, Der G, Gerbasi S, Cindolo L, Battaglia M, Ditonno P. Three years outcomes of transperineal laser ablation of the prostate. Minerva Urol Nephrol. 2023;75(4):471–8. https://doi.org/10.23736/s2724-6051.23.05270-9.
Patelli G. Commentary on “Ultrasound-guided Transperineal Prostate Thermal Ablation (TPTA) for Benign Prostatic Hyperplasia: Feasibility of an Outpatient Procedure using Radiofrequency Ablation.” Cardiovasc Intervent Radiol. 2025;48(10):1467–8. https://doi.org/10.1007/s00270-025-04081-z.
Szejnfeld D, Nunes TF. Response to commentary ‘ultrasound-guided transperineal prostate thermal ablation (TPTA) for benign prostatic hyperplasia: feasibility of an outpatient procedure using radiofrequency ablation.’ Cardiovasc Intervent Radiol. 2026;49(1):159–60. https://doi.org/10.1007/s00270-025-04220-6.
Liu R, Duan S, Cao H, Cao G, Chang Z, Zhang Y, et al. A pilot study of the shapes of ablation lesions in the canine prostate by laser, radiofrequency and microwave and their clinical significance. PLoS ONE. 2020;15(4):e0223229. https://doi.org/10.1371/journal.pone.0223229.
Article CAS PubMed PubMed Central Google Scholar
Wolters M, Krastel M, Winkler T, Idais H, Mazdak M, Tezval H, et al. Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study. Prostate Cancer Prostatic Dis. 2025;28(1):160–6. https://doi.org/10.1038/s41391-024-00836-w.
Tzelves L, Nagasubramanian S, Pinitas A, Juliebø-Jones P, Madaan S, Sienna G, et al. Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature. Ther Adv Urol. 2023;15:17562872231198634. https://doi.org/10.1177/17562872231198634.
Article PubMed PubMed Central Google Scholar
Manfredi C, Spirito L, Quattrone C, Bottone F, Romano L, Balsamo R, et al. Rezūm water vapor therapy vs. thulium laser enucleation for the treatment of benign prostatic hyperplasia in patients with large prostates: a multicenter prospective comparative study. Prostate Cancer Prostatic Dis. 2025;28(4):968–77. https://doi.org/10.1038/s41391-025-00971-y.
Comments (0)